Drug intelligence / Profile preview

betamethasone + lidocaine

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Intralesional, Intraarticular, Soft Tissue Injection
01

Overview

Betamethasone + lidocaine is a combination medication that pairs a corticosteroid (betamethasone) with a local anesthetic (lidocaine). This combination leverages the complementary mechanisms of both drugs: - **Betamethasone** is a long-acting corticosteroid with potent anti-inflammatory and immunosuppressive properties. It works by blocking the production of inflammatory chemical messengers (prostaglandins) that cause redness, swelling, and itching. - **Lidocaine** is an amide-type local anesthetic that stabilizes neuronal membranes by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby providing local anesthetic action. The combination is typically administered as an injectable suspension for various conditions requiring both pain relief and reduction of inflammation, including joint injections, soft tissue injections, and management of inflammatory conditions.

Brand names
ReadySharp Anesthetics Plus BetamethasoneCelestone Soluspan with lidocaine
Other names
rapidocain + betamethasone
02

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on betamethasone + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on betamethasone + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call